eFFECTOR Therapeutics (EFTR) Institutional Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free EFTR Stock Alerts $1.78 -0.11 (-5.82%) (As of 04/18/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for eFFECTOR Therapeutics (NASDAQ:EFTR)CurrentInstitutional OwnershipPercentage57.67%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$67.60MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$4.92M Get EFTR Insider Trade Alerts Want to know when executives and insiders are buying or selling eFFECTOR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EFTR Institutional Buying and Selling by Quarter Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story eFFECTOR Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/11/2024Vanguard Group Inc.574,413$268K0.0%+42.2%22.264% 2/15/2024Vanguard Group Inc.574,413$268K0.0%+42.2%22.221% 2/13/2024Northern Trust Corp160,812$75K0.0%+336.8%6.233% 11/13/2023Column Group LLC4,026,224$2.42M1.6%-6.6%9.496% 11/2/2023Sonora Investment Management Group LLC125,000$75K0.0%N/A0.295% 8/11/2023Renaissance Technologies LLC880,908$731K0.0%+512.2%2.078% Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/5/2023EP Wealth Advisors LLC17,607$1.65M0.0%N/A0.042% 5/16/2023Sea Otter Advisors LLC263,942$93K0.0%N/A0.622% 5/12/2023Renaissance Technologies LLC143,900$51K0.0%-34.6%0.339% 5/5/2023Carlyle Group Inc.4,822,114$1.69M0.1%N/A11.373% 2/15/2023CI Private Wealth LLC275,442$118K0.0%N/A0.658% 2/13/2023Renaissance Technologies LLC219,900$94K0.0%+12.5%0.525% 11/15/2022Two Sigma Investments LP47,223$27K0.0%N/A0.113% 11/15/2022Vanguard Group Inc.429,043$245K0.0%-17.0%1.024% 11/14/2022Renaissance Technologies LLC195,399$112K0.0%+567.2%0.466% 8/16/2022Callan Capital LLC20,000$28K0.0%N/A0.048% 8/13/2022Renaissance Technologies LLC29,288$42K0.0%N/A0.071% 8/2/2022Resolute Financial LLC30,000$43K0.0%N/A0.072% 8/1/2022Parallel Advisors LLC1,693,559$2.41M0.1%+150.0%4.092% 5/16/2022State Street Corp17,000$68K0.0%N/A0.041% 4/28/2022Parallel Advisors LLC677,452$2.74M0.1%N/A1.637% 2/15/2022SR One Capital Management LP6,822,114$56.49M31.9%N/A16.898% 2/9/2022Alps Advisors Inc.51,942$430K0.0%N/A0.129% 2/3/2022OUP Management Co. LLC1,025,697$8.49M3.8%N/A2.541% 11/16/2021Verition Fund Management LLC24,667$347K0.0%N/A0.061% 11/15/2021Abingworth LLP4,822,114$67.03M15.2%N/A11.964% 11/15/2021Sectoral Asset Management Inc2,882,744$40.50M3.4%N/A7.153% (Data available from 1/1/2016 forward) EFTR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EFTR shares? During the previous two years, 14 institutional investors and hedge funds held shares of eFFECTOR Therapeutics. The most heavily invested institutionals were Column Group LLC ($2.42M), Parallel Advisors LLC ($2.41M), Carlyle Group Inc. ($1.69M), EP Wealth Advisors LLC ($1.65M), Renaissance Technologies LLC ($731K), Vanguard Group Inc. ($268K), and CI Private Wealth LLC ($118K).Learn more on EFTR's institutional investors. What percentage of eFFECTOR Therapeutics stock is owned by institutional investors? 57.67% of eFFECTOR Therapeutics stock is owned by institutional investors. Learn more on EFTR's institutional investor holdings. Which institutional investors have been buying eFFECTOR Therapeutics stock? Of the 13 institutional investors that purchased eFFECTOR Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Carlyle Group Inc. ($4.82M), Parallel Advisors LLC ($1.69M), Renaissance Technologies LLC ($956.91K), Vanguard Group Inc. ($340.77K), CI Private Wealth LLC ($275.44K), Sea Otter Advisors LLC ($263.94K), and Sonora Investment Management Group LLC ($125K). How much institutional buying is happening at eFFECTOR Therapeutics? Institutional investors have bought a total of 8,733,567 shares in the last 24 months. This purchase volume represents approximately $182.37M in transactions. Which eFFECTOR Therapeutics major shareholders have been selling company stock? The following institutional investors have sold eFFECTOR Therapeutics stock in the last 24 months: Column Group LLC ($283.11K), Vanguard Group Inc. ($87.76K), and Renaissance Technologies LLC ($76K). How much institutional selling is happening at eFFECTOR Therapeutics? Institutional investors have sold a total of 446,860 shares in the last 24 months. This volume of shares sold represents approximately $6.17M in transactions. Related Companies: Bionomics Major Shareholders Clever Leaves Major Shareholders Processa Pharmaceuticals Major Shareholders Chemomab Therapeutics Major Shareholders Vaccinex Major Shareholders Galera Therapeutics Major Shareholders Cyclerion Therapeutics Major Shareholders Alterity Therapeutics Major Shareholders Can-Fite BioPharma Major Shareholders Virios Therapeutics Major Shareholders This page (NASDAQ:EFTR) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe “Perfect Storm” for GoldGold Safe ExchangeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.